A
A

AstraZeneca


Balita

UK Stocks-Factors to watch on July 26

July 26 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 25 points lower on Monday, according to financial bookmakers, while futures FFIc1 were down 0.50%. * ASTRZENECA: AstraZeneca AZN.L said the European Medicines Agency had recommended approving a medicine from its Alexion unit for treating a rare, deadly blood disorder in children and
A
V
R
U

AstraZeneca scours supply chain for more vaccine doses for Thailand, SE Asia

BANGKOK, July 24 (Reuters) - AstraZeneca Plc AZN.L is "scouring" its global supply chain to try and boost COVID-19 vaccine supplies to Thailand and Southeast Asia, its representative for the country said on Saturday, amidst speculations of local production shortfalls. The comments come after leaked letters Link showed last week that the drugmaker h
A

Australian PM apologises for 19 vaccine delays as cases spike

* NSW reports 124 new cases, from 110 a day earlier * Victoria reports 26 cases, up from 22 * More than half Australia's 25 mln population under lockdown By Renju Jose and Byron Kaye SYDNEY, July 22 (Reuters) - Australia's prime minister apologised for a sluggish COVID-19 vaccination programme on Thursday, while the country's most populous state re
A
P
Q

Leaked letters show AstraZeneca vaccine commitment not as Thailand claimed

By Panu Wongcha-um BANGKOK, July 19 (Reuters) - AstraZeneca Plc AZN.L has told Thailand it should be able to supply around 6 million doses of its COVID-19 vaccine per month, leaked correspondence showed, contradicting assertions by Thai officials that the government is owed 10 million. Thailand's push for 10 million monthly doses comes as it consid
A

Leaked letters show AstraZeneca vaccine commitment not as Thailand claimed

By Panu Wongcha-um BANGKOK, July 19 (Reuters) - AstraZeneca Plc AZN.L has told Thailand it should be able to supply around 6 million doses of its COVID-19 vaccine per month, leaked correspondence showed, contradicting assertions by Thai officials that the government had been promised 10 million. Thailand's push for 10 million monthly doses comes as
A

Leaked letters show AstraZeneca vaccine commitment not as Thailand claimed

By Panu Wongcha-um BANGKOK, July 19 (Reuters) - AstraZeneca Plc AZN.L has told Thailand it should be able to supply around 6 million doses of its COVID-19 vaccine per month, leaked correspondence showed, contradicting assertions by Thai officials that the government had been promised 10 million. Thailand's push for 10 million monthly doses comes as
A

UK Stocks-Factors to watch on July 19

(Updates futures, add news items) July 19 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Monday, with futures FFIc1 down 0.8%. * BP: BP BP.L and Germany's EnBW said they had submitted a joint bid for Scottish offshore wind acreage which could support wind projects with 2.9 gigawatts of capacity. * ASTRAZENECA: AstraZeneca AZN.L
A
B
N
U

Vaccine-starved Namibia receives Sinopharm boost

WINDHOEK, July 16 (Reuters) - Namibia, whose COVID-19 inoculation programme was halted by a lack of vaccines, received a boost on Friday with the arrival of 250,000 Sinopharm doses bought from China. Namibia has temporarily suspended delivering shots at major vaccination centres across the country after supplies ran low. It is classified as an uppe
A

Malaysia to allow commercial sale of 19 vaccines

By Rozanna Latiff and Joseph Sipalan KUALA LUMPUR, July 16 (Reuters) - Malaysia will soon allow the commercial sale of COVID-19 vaccines manufactured by Chinese firms Sinopharm 1099.HK and Sinovac SVA.O , the science minister said on Friday, as authorities try to ramp up inoculation rates amid surging cases. Malaysia has one of the region's highest
A
P

Thai hospital tycoon sticks to guns on vaccine claims

By Chayut Setboonsarng BANGKOK, July 16 (Reuters) - Thailand’s Thonburi Healthcare Group Pcl (THG) THG.BK doubled down on its outspoken chairman's claim to be buying Pfizer-BioNTech vaccines on Friday, helping its share price rise despite denials by both drugmakers. Dr. Boon Vanasin's claim that his group, a more than $800 million private medicin
A
P

India orders 660 mln vaccine doses amidst warnings over shortages - media

By Ankur Banerjee and Neha Arora July 16 (Reuters) - The Indian government has ordered 660 million vaccine doses for August-December, its largest procurement, local news reports said on Friday, as state authorities and health experts warned that shortages could leave millions vulnerable if coronavirus infections surge again. The federal government
A

Vietnam approves Johnson & Johnson's 19 vaccine as daily cases hit record

HANOI, July 15 (Reuters) - Vietnam on Thursday approved Johnson & Johnson's JNJ.N Janssen COVID-19 vaccine on Thursday for emergency use, as the country tries to boost supplies at a time of record numbers of new infections. The approval of the vaccine, the sixth brand to be endorsed in the Southeast Asian country, is part of Vietnam's efforts to ex
A

Drugmakers, oil majors drag FTSE 100 lower; Avast surges

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * Cybersecurity firm Avast surges on merger talks * Experian jumps on raising annual outlook * UK jobs surge in June with a record 7.3% pay rise * FTSE 100 down 1.1%, FTSE 250 off 1.0% (Updates to close) By Amal S July 15 (Reuters) - London'
A
G
U

Pfizer, BioNTech deny talks with Thai Thonburi Healthcare on vaccines

(Updates with denial from Pfizer) By Chayut Setboonsarng BANGKOK, July 15 (Reuters) - Pfizer PFE.N and Germany's BioNTech 22UAy.DE denied on Thursday that they were in talks with Thailand's Thonburi Healthcare Group Pcl THG.BK for a deal to import 20 million doses of the coronavirus vaccine to the Southeast Asian country. The chief of Thonburi Heal
A
P

Thailand says AstraZeneca asked to delay delivery of 61 mln vaccine doses

(Updates with Taiwanese comment, detail on Thai production) By Panarat Thepgumpanat and Panu Wongcha-um BANGKOK, July 15 (Reuters) - AstraZeneca AZN.L has asked Thailand to extend the timeline for the delivery of 61 million doses of its COVID-19 vaccine by five months, a deputy minister said on Thursday, a move likely to further disrupt the country
A

Thailand says AstraZeneca seeks to extend delivery timeline for 61 mln vaccine doses

(Corrects to AstraZeneca seeking to extend vaccine delivery, not Thailand, in headline and first paragraph) BANGKOK, July 15 (Reuters) - Thailand said on Thursday AstraZeneca AZN.L had asked to extend the timeline for the delivery of 61 million doses of its COVID-19 vaccine to the Southeast Asian country from December to May 2022, Deputy Health Min
A

EU regulator weighing mixing 19 vaccines, booster doses

* Says 'not in position' to advise on use of different doses * Says countries may adapt strategies based on available evidence * Finds no 'clear' link between Moderna shot, new blood condition * EC says it follows science, but needs to be prepared By Pushkala Aripaka July 14 (Reuters) - Europe's drug regulator on Wednesday refrained from making any
A
P

Vietnam says Pfizer to provide 20 mln vaccine doses, consider tech transfer

HANOI, July 14 (Reuters) - Vietnam on Wednesday said U.S. vaccine maker Pfizer PFE.N would provide an additional 20 million doses of its COVID-19 mRNA shot, as the country tries to shore up supplies at a time of record number of new infections. The additional Pfizer-BioNTech 22UAy.DE vaccines would be used for 12-18 year olds, its health ministry s
A
P

Thai state drugmaker sues critic of its vaccine procurement

BANGKOK, July 14 (Reuters) - Thailand's state drugmaker on Wednesday said it had initiated a defamation suit against the prominent chairman of a private hospital operator over his criticism of its procurement of Moderna MRNA.O COVID-19 vaccines. The Government Pharmaceutical Organization (GPO) suit accuses Boon Vanasin of providing false informatio
A
P

Thailand considering limits on AstraZeneca vaccine exports

* Curbs would hurt vaccine efforts for neighbours * Thailand battling worst outbreak, low vaccine rate * Plan agreed in principle - Thai official (Updates with AstraZeneca statement) By Panarat Thepgumpanat and Panu Wongcha-um BANGKOK, July 14 (Reuters) - Thailand is considering imposing limits on exports of locally manufactured AstraZeneca AZN.L C
A



Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Gumagamit kami ng cookies para mabigyan ka ng mahusay na karanasan sa aming website. Magbasa pa o palitan ang iyong cookie settings.

Babala sa Risk: Ang iyong kapital ay maaaring malugi. Ang mga produktong naka-leverage ay maaaring hindi para sa lahat. Tingnan ang aming Risk Disclosure.